Akebia Therapeutics (AKBA) Stock Chart & Stock Price History $3.60 -0.03 (-0.69%) Closing price 07/3/2025 02:45 PM EasternExtended Trading$3.62 +0.01 (+0.28%) As of 07/3/2025 04:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Akebia Therapeutics Stock Price Performance The Akebia Therapeutics (AKBA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 280.88%, with a year-to-date return of 89.74%. In the past month, the stock has decreased 0.96%, reflecting recent market activity. As of the latest close, Akebia Therapeutics traded at $3.61 with a market cap of $946.82 million and volume of 1.57 million shares. Five years ago, the stock traded at $13.08, representing a 72.44% decrease over that period. At the time, it had a market cap of $1.77 billion and a volume of 1.28 million shares. Receive AKBA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Akebia Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.23%1 Month Performance-0.96%3 Month Performance+103.67%Year-To-Date Performance+89.74%1 Year Performance+280.88%5 Year Performance-72.44% AKBA Stock Chart for Friday, July, 4, 2025 AKBA Chart by TradingView Akebia Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$3.61$3.61$3.63$3.561.57 million shs$946.82 million07/03/2025$3.63$3.61-0.69%$3.63$3.561.57 million shs$946.82 million07/02/2025$3.57$3.63+1.68%$3.75$3.484.62 million shs$953.38 million07/01/2025$3.64$3.57-1.92%$3.68$3.495.02 million shs$937.63 million06/30/2025$3.65$3.64-0.27%$3.74$3.632.85 million shs$956.00 million06/27/2025$3.74$3.65-2.41%$3.76$3.608.48 million shs$958.64 million06/26/2025$3.68$3.74+1.63%$3.76$3.613.09 million shs$982.27 million06/25/2025$3.67$3.68+0.27%$3.79$3.563.77 million shs$966.52 million06/24/2025$3.64$3.67+0.82%$3.87$3.645.30 million shs$963.89 million06/23/2025$3.68$3.64-1.09%$3.68$3.485.30 million shs$956.01 million Get the Latest News and Ratings for AKBA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akebia Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025$3.56$3.68+3.37%$3.69$3.529.32 million shs$966.52 million06/19/2025$3.56$3.56$3.62$3.483.60 million shs$935.00 million06/18/2025$3.50$3.56+1.71%$3.62$3.483.60 million shs$935.00 million06/17/2025$3.58$3.50-2.23%$3.59$3.463.98 million shs$919.23 million06/16/2025$3.56$3.58+0.56%$3.68$3.543.53 million shs$940.24 million06/13/2025$3.65$3.56-2.47%$3.70$3.516.47 million shs$934.98 million06/12/2025$3.57$3.65+2.24%$3.70$3.494.11 million shs$958.62 million06/11/2025$3.92$3.57-8.93%$3.98$3.566.99 million shs$937.61 million06/10/2025$3.83$3.92+2.35%$3.93$3.4811.06 million shs$1.03 billion06/09/2025$3.97$3.83-3.53%$4.08$3.838.10 million shs$1.01 billion06/06/2025$3.69$3.97+7.59%$4.00$3.668.17 million shs$1.04 billion06/05/2025$3.64$3.69+1.37%$3.73$3.525.72 million shs$969.13 million06/04/2025$3.42$3.64+6.43%$3.73$3.4212.18 million shs$956.00 million06/03/2025$3.25$3.42+5.23%$3.49$3.227.16 million shs$898.22 million Related Companies MRUS Stock Price Chart ACLX Stock Price Chart ACAD Stock Price Chart SWTX Stock Price Chart RARE Stock Price Chart AAPG Stock Price Chart PTGX Stock Price Chart RNA Stock Price Chart SRRK Stock Price Chart MLTX Stock Price Chart Receive AKBA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Akebia Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AKBA) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredRevealed: NEW A.I. revolution (nobody is talking about)Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to...Behind the Markets | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akebia Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akebia Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AKBA Stock Alerts